Advisornet Financial’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43K Hold
600
– – ﹤0.01% 1839
2026
Q1
$3.77K Buy
600
+500
+500% +$4.64K ﹤0.01% 1796
2025
Q4
$1.23K Hold
100
– – ﹤0.01% 1962
2025
Q3
$2.05K Hold
100
– – ﹤0.01% 1865
2025
Q2
$1.35K Hold
100
– – ﹤0.01% 1900
2025
Q1
$866 Hold
100
– – ﹤0.01% 1901
2024
Q4
$486 Hold
100
– – ﹤0.01% 1784
2024
Q3
$772 Hold
100
– – ﹤0.01% 1975
2024
Q2
$1K Hold
100
– – ﹤0.01% 1812
2024
Q1
$1.22K Hold
100
– – ﹤0.01% 1710
2023
Q4
$1.43K Hold
100
– – ﹤0.01% 1804
2023
Q3
$778 Hold
100
– – ﹤0.01% 1865
2023
Q2
$1.43K Hold
100
– – ﹤0.01% 1798
2023
Q1
$1.46K Hold
100
– – ﹤0.01% 1782
2022
Q4
$1.68K Hold
100
– – ﹤0.01% 1708
2022
Q3
$1K Hold
100
– – ﹤0.01% 1798
2022
Q2
$3K Buy
+100
New +$2.96K ﹤0.01% 1633
2021
Q1
– Sell
-100
Closed -$3K – 1807
2020
Q4
$3K Buy
+100
New +$2.45K ﹤0.01% 1513

Other funds holding OPRX

Advisornet Financial's OPRX Position: Q2 2026 in Review

Advisornet Financial held its OptimizeRx (OPRX) position steady in Q2 2026 at 600 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Advisornet Financial first reported a position in OPRX in Q4 2020 and has held it in 18 quarters since. The position peaked at $3.77K in Q1 2026. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Advisornet Financial held 600 shares of OptimizeRx worth $3.43K as of Q2 2026.
  • Advisornet Financial left its OptimizeRx share count unchanged in Q2 2026.
  • OptimizeRx made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1839 holding.
  • Advisornet Financial first reported a position in OptimizeRx in Q4 2020 and has held it in 18 quarters since.
  • Advisornet Financial's OptimizeRx position peaked at $3.77K in Q1 2026.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.